~~<i id='9771B47A2A'><strike id='9771B47A2A'><tt id='9771B47A2A'><pre id='9771B47A2A'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

WSS

Notifications
- explore
The Supreme Court will review a ruling striking down a domestic violence federal gun ban
log on

focus

hotspot

author：leisure time 2025-09-06 04:38:18 - browse：9

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： FDA advisory panel to debate high blood pressure devices

entertainment

focus

knowledge

focus

JohnMoore/GettyImages“Howhastheclinicalworkyoudoaffectedyoupersonally?”We’dcometotheQ&Apartofthe

WSS

Roche's accidental data boosts hopes for anti

Childbirth

Stigma and the return of syphilis

AI used to predict Covid

Adam's Biotech Scorecard: Do Sarepta's exon

Average age of first period drops to 11.9 years, study shows

focus

hotspot

entertainment

Activists slam private health insurers over coverage restrictions

As obesity drug market grows, telehealth companies court payers

In Memoriam: Notable people who died in 2023

Childbirth

After affirmative action ruling, medical educators look to 'holistic review'

David Sabatini, ex

Peter Hotez and the public health issue of online harassment

Biohaven protein

Moonlake's readout produced a cash windfall. Risks remain

Republicans love RFK Jr. What's that tell us about health in 2024?

focus

Study: Spinal cord stimulation helps patients with paralysis walk again

Heat waves linked to early deliveries, preterm births in new study

Scientists successfully use ultrasound imaging to map brain activity

Intellia plays down concerns on accidental germline transmission

How the drug

Health officials lay out plans to cope with respiratory virus season

knowledge

knowledge

focus

focus